Phenobarbitone prophylaxis for neonatal hyperbilirubinemia.
D000017:ABO Blood-Group System; D001663:Bilirubin / Q000378:metabolism; D001787:Blood Group Incompatibility / Q000378:metabolism; D005260:Female; D006723:Hong Kong; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control*; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control*; D008297:Male; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000627:therapeutic use*; D011247:Pregnancy
D000017:ABO Blood-Group System; D001663:Bilirubin; D010634:Phenobarbital